Bull Street Advisors LLC decreased its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 0.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 22,969 shares of the company’s stock after selling 100 shares during the period. Procter & Gamble comprises 1.8% of Bull Street Advisors LLC’s holdings, making the stock its 19th largest holding. Bull Street Advisors LLC’s holdings in Procter & Gamble were worth $3,659,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in PG. Brighton Jones LLC boosted its position in shares of Procter & Gamble by 51.5% during the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock worth $6,717,000 after acquiring an additional 13,617 shares in the last quarter. Taylor Financial Group Inc. lifted its stake in Procter & Gamble by 10.6% in the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock valued at $493,000 after purchasing an additional 277 shares during the last quarter. GAMMA Investing LLC lifted its stake in Procter & Gamble by 22.4% in the 1st quarter. GAMMA Investing LLC now owns 46,658 shares of the company’s stock valued at $7,951,000 after purchasing an additional 8,537 shares during the last quarter. Opal Wealth Advisors LLC bought a new position in Procter & Gamble in the 1st quarter valued at approximately $149,000. Finally, Missouri Trust & Investment Co lifted its stake in Procter & Gamble by 3.5% in the 1st quarter. Missouri Trust & Investment Co now owns 13,442 shares of the company’s stock valued at $2,291,000 after purchasing an additional 457 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Insider Activity at Procter & Gamble
In other news, CEO Jon R. Moeller sold 11,684 shares of the stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the completion of the sale, the chief executive officer directly owned 319,932 shares in the company, valued at $48,703,248.36. This represents a 3.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Andre Schulten sold 4,252 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $647,281.96. Following the sale, the chief financial officer owned 53,992 shares of the company’s stock, valued at approximately $8,219,202.16. This trade represents a 7.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 149,763 shares of company stock valued at $23,421,279 over the last 90 days. 0.20% of the stock is owned by company insiders.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. The firm had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company’s revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.
Wall Street Analyst Weigh In
Several brokerages recently commented on PG. JPMorgan Chase & Co. dropped their price objective on shares of Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating for the company in a research note on Friday. BNP Paribas reissued an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a research note on Friday, August 15th. BNP Paribas Exane dropped their price objective on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research note on Tuesday, September 23rd. UBS Group dropped their price objective on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a research note on Wednesday. Finally, Barclays dropped their price objective on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 1st. Eleven equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $172.21.
Check Out Our Latest Analysis on PG
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More
- Five stocks we like better than Procter & Gamble
- Investing in the High PE Growth Stocks
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- What Are Trending Stocks? Trending Stocks Explained
- Could Target’s Week of Discounts Come Full Circle for Investors?
- How to start investing in penny stocks
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.